The Endovascular Treatment Devices Market Size is valued at 3486.16 Million in 2024 and is predicted to reach 8398.23 Million by the year 2034 at a 9.4% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Endovascular surgery is a cutting-edge, minimally invasive operation used to treat medical disorders affecting the blood vessels, such as an aneurysm, a bulging or "ballooning" of the blood vessel. The procedure begins with a bodily incision to allow access to the blood vessels. A flexible, plastic tube, stents, or catheter is put into the damaged blood vessel to allow medication withdrawal or delivery from the patient's bloodstream. Endovascular treatment devices are utilized in various therapies, including intravenous antibiotic treatment, long-term intravenous nutrition, chemotherapy, and blood transfusions.
The endovascular treatment devices market is expected to grow during the forecast period, owing to factors such as an increasing geriatric population base, an increase in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased expenditure on research and development by market participants. However, the high expense of endovascular operations, a lack of awareness in economically underdeveloped nations, and a shortage of competent surgeons to execute the surgeries stifle market growth.
Due to the medical field's focus on treating COVID-19, funding for R&D efforts connected to endovascular therapy has been curtailed, and this segment has been neglected, resulting in a negative impact on the endovascular treatment devices market. Rising healthcare spending is accelerating research and development, and breakthrough product launches in endovascular treatment devices have increased the usage of these devices.
The Endovascular Treatment Devices market is segmented on the product, procedure, and indication. Based on product, the market is segmented into percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices. Based on procedure, the Endovascular Treatment Devices are segmented into balloon angioplasty, stent replacement, drug-eluting stents, renal artery angioplasty and stenting carotid artery, thrombosis, renal artery angioplasty and stenting, transfemoral carotid artery revascularization and intravascular brachytherapy and carotid artery stenting. Based on the application, the Endovascular Treatment Devices are segmented into pulmonary, vascular, cardiology surgery, neurology and radiology.
Based on product, the market is segmented into percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices. The percutaneous endovascular aneurysm repair (EVAR) segment dominated the market. Endovascular Aneurysm Repair (EVAR), a popular, safe, and effective procedure, is frequently used to repair abdominal aortic aneurysms. The surgical cutdown that is commonly employed to treat this problem over the common femoral arteries has been replaced by percutaneous access methods in several recent studies. By learning more about different percutaneous procedures, including dangers, issues, adjuncts, and alternative approaches, one can improve the results and accessibility of EVAR.
Based on the application, the Endovascular Treatment Devices are segmented into pulmonary, vascular, cardiology surgery, neurology and radiology. The cardiology segment dominated the market. The prevalence of cardiovascular disorders is rising worldwide, which helps this market grow. Cardiovascular diseases (CVDs) are the major reason for death worldwide. Endovascular therapy, which treats cardiovascular disease from within the blood artery, changes how heart attacks, strokes, and other cardiovascular disorders are treated. Many cardiac and vascular conditions that once needed invasive surgery can now be treated internally. These are the main elements influencing the segment's expansion.
The North American Endovascular Treatment Devices market is expected to register the highest market share in revenue in the near future. The expansion of the market is attributable to an increase in surgical procedures and a rise in the preference for these devices among medical professionals, which has prompted large companies to concentrate on the creation of cutting-edge medical devices in these nations. The obesity and diet epidemics in the area, together with the introduction of new products as a result of the presence of top manufacturers there, will all contribute to the region's Endovascular Therapy Devices market expansion. The endovascular treatment device market is anticipated to develop in response to a favourable reimbursement environment for endovascular operations. In addition, Asia Pacific is projected to grow rapidly in the global Endovascular Treatment Devices market. Increased medical advancements have contributed to the endovascular treatment devices market revenue growth in this area, leading to continuing industry expansion. Increased R&D efforts and medical improvements made by significant participants in the region's nations can also be credited with growth.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 3486.16 Million |
|
Revenue Forecast In 2034 |
USD 8398.23 Million |
|
Growth Rate CAGR |
CAGR of 9.4% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million, volume (units) and CAGR from 2024 to 2031 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product, Procedure, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; Japan; India; South Korea; South East Asia |
|
Competitive Landscape |
Cardinal Health , Endospan, Geting AB, Bosten Scientific Corporation, Inspire MD, Japan Lifeline Co., Ltd., Medtronic, Lombord Medical, Penumbra, Inc., Terumo Corporation |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Endovascular Treatment Devices Market Snapshot
Chapter 4. Global Endovascular Treatment Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Percutaneous Endovascular Aneurysm Repair (EVAR)
5.2.2. Fenestrated EVAR
5.2.3. Aortic Stents Biodegradable Stents
5.2.4. Self- Expanding Nitinol Stents
5.2.5. Thoracic Aortic Aneurysm Grafts
5.2.6. Other Devices
Chapter 6. Market Segmentation 2: by Procedure Estimates & Trend Analysis
6.1. by Procedure & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Procedure:
6.2.1. Ballon Angioplasty
6.2.2. Angioplasty With Stent Replacement
6.2.3. Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
6.2.4. Thrombosis
6.2.5. Renal Artery Angioplasty and Stenting
6.2.6. Transfemoral Carotid Artery Revascularization
6.2.7. Intravascular Brachytherapy
6.2.8. Carotid Artery Stenting
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Pulmonary
7.2.2. Vascular
7.2.3. Cardiology Surgery
7.2.4. Neurology
7.2.5. Radiology
Chapter 8. Endovascular Treatment Devices Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Endovascular Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America Endovascular Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Procedure, 2021-2034
8.1.3. North America Endovascular Treatment Devices Market revenue (US$ Million) by Application, 2021-2034
8.1.4. North America Endovascular Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Endovascular Treatment Devices Market revenue (US$ Million) by Product Type, 2021-2034
8.2.2. Europe Endovascular Treatment Devices Market revenue (US$ Million) by Procedure, 2021-2034
8.2.3. Europe Endovascular Treatment Devices Market revenue (US$ Million) by Application, 2021-2034
8.2.4. Europe Endovascular Treatment Devices Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Endovascular Treatment Devices Market revenue (US$ Million) by Product Type, 2021-2034
8.3.2. Asia Pacific Endovascular Treatment Devices Market revenue (US$ Million) by Procedure, 2021-2034
8.3.3. Asia-Pacific Endovascular Treatment Devices Market revenue (US$ Million) by Application, 2021-2034
8.3.4. Asia Pacific Endovascular Treatment Devices Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Endovascular Treatment Devices Market revenue (US$ Million) by Product Type, 2021-2034
8.4.2. Latin America Endovascular Treatment Devices Market revenue (US$ Million) by Procedure, 2021-2034
8.4.3. Latin America Endovascular Treatment Devices Market revenue (US$ Million) by Application, 2021-2034
8.4.4. Latin America Endovascular Treatment Devices Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Endovascular Treatment Devices Market revenue (US$ Million) by Product Type, 2021-2034
8.5.2. Middle East & Africa Endovascular Treatment Devices Market revenue (US$ Million) by Procedure, 2021-2034
8.5.3. Middle East & Africa Endovascular Treatment Devices Market revenue (US$ Million) by Application, 2021-2034
8.5.4. Middle East & Africa Endovascular Treatment Devices Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Cardinal Health
9.2.2. Endospan
9.2.3. Getinge AB
9.2.4. Boston Scientific Corporation
9.2.5. InspireMD
9.2.6. Japan Lifeline Co., Ltd.
9.2.7. Medtronic
9.2.8. Lombard Medical
9.2.9. Penumbra, Inc.
9.2.10. Terumo Corporation
9.2.11. Other Prominent Players
By Product-
By Procedure-
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
